| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |